|
VYGR Voyager Therapeutics Inc 1640266 |
| Balance Sheet |
|
Current Assets
|
$146,981,000.00 |
|
Assets
|
$219,325,000.00 |
|
Current Liabilities
|
$17,453,000.00 |
|
Liabilities
|
$45,656,000.00 |
|
Equity
|
$173,669,000.00 |
|
Shares Out
|
60310526.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-33,419,000.00 |
|
Investing Cash Flow
|
$8,101,000.00 |
| Market Analysis |
Market Cap
|
$188,771,946.38 |
|
Price
|
$3.00 |
|
BVPS
|
2.88 |
|
PB
|
1.09 |
|
EPS
|
-0.47 |
|
PS
|
21.98 |
|
FCF
|
$-33,433,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:34 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:31 |
|
| Apr |
May |
Jun |
| 2026-03-09 |
-0.46 |
|
|
2026-05-07 |
-0.47 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-0.57 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.47 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VYGR documents filed with the SEC.
VYGR Filings
Clear
